CA19-9 Testing – Carbohydrate Antigen 19-9 (i.e. CA19-9), is a tumour marker commonly used in the medical field to help detect and monitor certain types of cancer — particularly pancreatic cancer. It is a type of protein found in the blood, and elevated levels may indicate the presence of malignancies.
While CA19-9 is not used as a sole diagnostic tool, it plays a valuable role in tracking the progression of pancreatic cancer, especially after treatment or surgery.
See A Pancreas Surgeon Or Specialist Regarding Your Concerns About Pancreatic Cancer
Contact UsBack To: Pancreas Cancer Main Page
Why Is CA19-9 Important For Pancreatic Cancer Testing?
Pancreatic cancer often goes undetected in its early stages due to vague symptoms. As a result, many patients are diagnosed only after the disease has advanced. The CA19-9 test, when combined with imaging scans and clinical evaluation, may help identify suspicious cases earlier — particularly in high-risk individuals.
It’s important to note that CA19-9 is not a standalone screening test, but rather part of a broader diagnostic approach. In Singapore, it is frequently used by specialists to:
- Monitor tumour recurrence after surgery
- Evaluate how well treatment is working
- Aid in detecting metastases or progression
Who Should Consider CA19-9 Testing In Singapore?
Though not routinely recommended for the general population, CA19-9 testing may be advised if you fall into a high-risk category, such as:
- Family history of pancreatic cancer
- Chronic pancreatitis
- Long-standing diabetes
- Smoking history
In Singapore, individuals with these risk factors may benefit from consulting a pancreatic surgeon or oncologist to assess whether CA19-9 testing is appropriate.
Browse Cancer Marker Screening Packages
Limitations Of CA19-9 As A Screening Tool
While CA19-9 is the most widely used biomarker for monitoring pancreatic cancer, it is not recommended as a standalone screening tool for the general population. In Singapore, where pancreatic cancer is a leading cause of cancer-related deaths, understanding these limitations is crucial for accurate health assessment.
The primary reasons for its limited utility in screening include:
Lack Of Specificity (False Positives)
A significant drawback of CA19-9 is that it is not exclusive to pancreatic cancer. Elevated levels are frequently found in several benign (non-cancerous) conditions, which can lead to unnecessary anxiety and invasive follow-up tests.
- Biliary Obstruction: Gallstones, jaundice, or bile duct inflammation (cholangitis) can cause CA19-9 levels to spike significantly.
- Benign Pancreatic Disease: Chronic or acute pancreatitis and benign pancreatic cysts often show elevated markers.
- Other Cancers: It may also be raised in cancers of the liver, stomach, colon, and lungs.
The “Non-Secretor” Problem (False Negatives)
Approximately 5% to 10% of the population cannot produce the CA19-9 antigen due to their genetic makeup (specifically, those who are Lewis Antigen negative). In these individuals, CA19-9 levels will remain normal or undetectable even if a large, aggressive tumour is present. This creates a dangerous “false sense of security.”
Low Sensitivity For Early-Stage Detection
Screening tools are most effective when they can catch “Stage 1” disease. However, CA19-9 is often only significantly elevated in the advanced stages of pancreatic cancer. By the time the marker is high enough to be noticed in a routine screen, the cancer may have already progressed to a point where surgical resection is more difficult.
Poor Positive Predictive Value (PPV)
Because pancreatic cancer is relatively rare in the general population compared to benign conditions, the Positive Predictive Value of a CA19-9 test is extremely low (often estimated at less than 1%). This means that if an asymptomatic person has an elevated result, there is a less than 1% chance that it is actually caused by pancreatic cancer.
What To Do If Your CA19-9 Test Results Show You Are At Risk?
If you’ve received an abnormal CA 19-9 result, do not panic. The test result is only part of the bigger picture. Make an appointment to consult an experienced HPB surgeon. The surgeon will evaluate your CA 19-9 result with your symptoms, imaging scans, and any endoscopic or biopsy findings. The surgeon may also order further tests such as CT, MRI, or PET scans.
Our Preferred Doctor For Pancreas Cancer Treatment
If you are looking for a HPB (Hepatopancreatobiliary) surgeon for treatment or evaluation of CA19-9 results, you can consider our Preferred Doctors:
- Dr Lee Lip Seng is a highly regarded surgeon who specialises in advanced minimally invasive robotic and laparoscopic techniques for the treatment of complex liver, pancreatic, and gallbladder conditions. Patients frequently seek his care due to his exceptional clinical expertise and a steadfast commitment to delivering compassionate, patient-centred results.
[SG] Featured Doctor- Dr Kevin Koo
Where To Get CA19-9 Testing In Singapore
Pancreatic cancer screening, including CA19-9 testing, is available at many public and private medical centres across Singapore. If you’re experiencing persistent symptoms like abdominal pain, jaundice, or weight loss, or you have a family history of cancer, it’s advisable to consult a pancreatic specialist or surgeon for further evaluation.
Early detection can make a life-saving difference — speak to a specialist today.
Contact UsBrowse Cancer Marker Screening Packages
Back To: Pancreas Cancer Main Page
All content on this site is informative only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment, and should never be relied upon for specific medical advice. If you are experiencing a medical emergency, call 995 immediately or go to the nearest Accident & Emergency department.
health365.sg is a member of Group 365Asia.